A tech company has decided to apply ISO/IEC 42001 specifically to integrate the AIMS with existing management systems, such as the Information Security Management System and the Business Continuity Management System. Which part of ISO/IEC 42001 should the company use as guidance on aligning the AIMS with these systems to ensure cohesive objectives, streamlined processes, and unified documentation?

• A. Annex B
• B. Annex D
• C. Annex C

In the functional view of an AI system, what role does the processing component play?

• A. It encompasses introducing new data into the model, enabling it to generate predictions, undertake actions, or offer recommendations
• B. It involves the decision-making processes of data scientists, engineers, and others responsible for the system's creation, maintenance, and management
• C. It pertains to the model's training phase, where the system learns to recognize patterns and make decisions

A software development company is well-known for its innovative practices and collaborative work environment. The CEO, Alex, has fostered a work culture where team input is highly valued in shaping the company's strategic direction. Alex often organizes brainstorming sessions and workshops, inviting employees from various departments to share their insights and suggestions on new projects, company policies, and workflow improvements. While Alex ensures that every team member feels heard and valued, the final decisions on project directions, key company policies, and strategic initiatives rest with Alex. Which type of leadership does Alex most closely embody?

• A. Autocratic
• B. Laissez-faire
• C. Bureaucratic
• D. Democratic

Scenario 4 (continued):
BioNovaPharm, a German biopharmaceutical company, has implemented an artificial intelligence management system AIMS based on ISO/IEC 42001 to optimize various aspects of drug discovery, including analyzing extensive biological data, identifying potential drug candidates, and streamlining clinical trial processes. After having the AIMS in place for over a year, the company contracted a certification body and is now undergoing an AIMS audit to obtain certification against ISO/IEC 42001.
Adopting a risk-based approach, the audit team focused on risk throughout their activities. The level of detail outlined in the audit plan corresponded to the scope and complexity of the audit. The team employed a ranking system for detailed audit procedures, prioritizing those with the highest risk.
Once the stage 1 audit began, the audit team started reviewing the auditee's documented information. To assess whether BioNovaPharm complies with the legal and regulatory requirements related to incident communication, the audit team examined evidence provided by the company's external legal office. The evidence confirmed that BioNovaPharm applies the requirements of the EU Al Act, which mandates that providers of high-risk Al systems report serious incidents to relevant authorities.
Following the completion of the stage 1 audit, John, an audit team member, documented the stage 1 audit outputs, including the observations of the audit team that could result in nonconformities during the on-site audit. However, the audit team leader, Emma, who was overseeing the audit activities, observed that John failed to document significant observations related to the lack of transparency in the Al decision-making processes of BioNovaPharm. Considering that Emma observed John's lack of competence in undertaking some audit activities, a disciplinary note was recorded for John.
Question:
Which of the following AI applications for auditing did the audit team employ?

• A. Automated planning
• B. Augmented analysis
• C. Automated data validation
• D. Augmented audit interviews